Aethlon Medical(US:AEMD) Investorideas.com·2026-03-12 14:20Core Insights - Aethlon Medical, Inc. (NASDAQ: AEMD) is evaluating strategic opportunities and has engaged Maxim Group LLC as its exclusive financial advisor for this process [3][4] - The engagement with Maxim follows preliminary interest in potential strategic transactions, including partnerships, mergers, and acquisitions [4] - The company continues its development activities, having completed the second cohort of an Australian oncology trial, with safety data to be submitted for review [5] Company Overview - Aethlon Medical focuses on developing the Hemopurifier, a clinical-stage immunotherapeutic device aimed at treating cancer and life-threatening viral infections [8] - The Hemopurifier has shown promise in human studies for removing life-threatening viruses and harmful extracellular vesicles (EVs) from biological fluids [8] - The device is designated as a Breakthrough Device by the FDA for treating advanced or metastatic cancer and life-threatening viruses not addressed by approved therapies [8]